Doxycycline and Pomalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxycycline (doxycycline hyclate) and Pomalidomide (pomalidomide). Common drug interactions include lower respiratory tract infection among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Doxycycline and Pomalidomide. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Doxycycline?

Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,868 Doxycycline users. Check the latest studies of Doxycycline.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

33 people who take Doxycycline and Pomalidomide together, and have interactions are studied.

Doxycycline and Pomalidomide drug interactions.

What are the common drug interactions of Doxycycline and Pomalidomide, by gender? *:

female:

  1. Lower respiratory tract infection
  2. Anaemia (lack of blood)
  3. Leukopenia (less number of white blood cells in blood)
  4. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  5. Pneumonia
  6. Dizziness
  7. Lymphocyte count decreased
  8. Circulatory collapse
  9. Fall
  10. Plasma cell myeloma (cancer that begins in plasma cells)

male:

  1. Anaemia (lack of blood)
  2. Abdominal pain
  3. Alanine aminotransferase increased
  4. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  5. Blood alkaline phosphatase increased
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Haemoglobin decreased
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Plasma cell myeloma (cancer that begins in plasma cells)
  10. Respiratory tract infection

What are the common drug interactions of Doxycycline and Pomalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Pneumonia
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Influenza like illness
  5. Lymphocyte count decreased
  6. Abdominal pain lower
  7. Circulatory collapse
  8. Fall
  9. Gastritis (inflammation of stomach)
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 32 people, 96.97%
  2. Lower Respiratory Tract Infection: 6 people, 18.18%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 15.15%
  4. Gout (uric acid crystals building up in the body): 5 people, 15.15%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 15.15%
  6. Cardiac Failure: 5 people, 15.15%
  7. Constipation: 5 people, 15.15%
  8. Respiratory Tract Infection: 4 people, 12.12%
  9. Mucosal Infection (infection of mucous membrane): 4 people, 12.12%
  10. Itching: 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Doxycycline and Pomalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Doxycycline and Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Doxycycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxycycline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pomalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxycycline hyclate and pomalidomide (the active ingredients of Doxycycline and Pomalidomide, respectively), and Doxycycline and Pomalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: